May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 27, 2025

New FDA approved Biosimilar Targets IL-12/23

The FDA has approved Starjemza, a ustekinumab biosimilar, for multiple inflammatory conditions.

Conexiant

May 27, 2025

Food Allergy in Toddlers Raises Atopic Risk

Children with food allergy and atopic dermatitis before age 3 were more likely to develop asthma, allergic rhinitis, and anaphylaxis by school age, a large birth cohort study found.

Conexiant

May 22, 2025

New FDA-Approved Topical Foam for Scalp Psoriasis

The FDA has approved roflumilast (ZORYVE) foam 0.3% for once-daily treatment of plaque psoriasis in patients aged 12 and older, including hard-to-treat scalp and body areas..

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 22, 2025

Dual Inhaler Halves Mild Asthma Attacks in Trial

As-needed albuterol-budesonide was superior to albuterol alone for mild, uncontrolled asthma in new trial.

Conexiant

May 20, 2025

Clinical Trials Missing in Half of AI Tools

Researchers analyzed FDA-approved AI-enabled medical devices and reported that clinical performance and subgroup data were frequently missing.

Conexiant

May 19, 2025

Zyrtec and Xyzal: FDA Issues Withdrawal Syndrome Warning

A new safety alert highlights the potential for severe itch following discontinuation of long-term cetirizine and levocetirizine use.

Conexiant

May 19, 2025

 Cat or Dog Allergies: Which Is Worse?

Study finds cat allergies 2.5 times more common than dog allergies in urban asthma patients, with similar severity markers.

Conexiant